Lynch Andrew, Sobuwa Simpiwe, Castle Nicholas
Department of Emergency Medical Care, Durban University of Technology, South Africa.
Hamad Medical Corporation, Qatar.
Afr J Emerg Med. 2020 Dec;10(4):243-248. doi: 10.1016/j.afjem.2020.08.001. Epub 2020 Sep 3.
Evidence-based guidelines advocate percutaneous coronary intervention (PCI) as the mainstay reperfusion strategy for ST-segment elevation myocardial infarction (STEMI). However, the South African health system is not well positioned to provide PCI as a 'mainstay strategy'. In response, the Health Professions Council of South Africa approved the use of prehospital thrombolysis (PHT) for emergency care practitioners in 2009. However, since its approval, prehospital thrombolysis has failed to reach a level of systematic uptake indicative of successful implementation. The current study aimed to explore, through a qualitative inquiry, barriers to PHT for the treatment of myocardial infarction within a South African context.
A qualitative single-case study design was used where a series of semi-structured interviews were conducted involving purposefully selected participants. The case comprised a nationalised private emergency medical service, and participants were selected in view of relevant experience and knowledge. Requisite data was conceptualised through the consolidated framework for implementation research, and thematic analysis outlined the data coding procedures of the study.
The study identified potential barriers to the implementation of PHT. These comprised cost, logistics, inter-professional collaboration, leadership engagement, and beliefs or scepticism associated with PHT.
A lack of strategic implementation has resulted in a poor introduction of evidenced-based prehospital cardiac care, affecting vulnerable populations who may have otherwise benefited from receiving this level of care. Given the time-sensitive nature of STEMI management, and severely limited access to 'primary reperfusion', PHT resembles not only a logical but also appealing solution in the South African context.
循证指南提倡将经皮冠状动脉介入治疗(PCI)作为ST段抬高型心肌梗死(STEMI)的主要再灌注策略。然而,南非的医疗系统并不适合将PCI作为“主要策略”来实施。作为回应,南非卫生专业人员理事会于2009年批准急救人员使用院前溶栓(PHT)。然而,自批准以来,院前溶栓未能达到表明成功实施的系统采用水平。本研究旨在通过定性调查,探讨南非背景下院前溶栓治疗心肌梗死的障碍。
采用定性单案例研究设计,进行了一系列半结构化访谈,涉及有目的地挑选的参与者。该案例包括一家国有化的私人紧急医疗服务机构,根据相关经验和知识挑选参与者。所需数据通过实施研究的综合框架进行概念化,主题分析概述了该研究的数据编码程序。
该研究确定了院前溶栓实施的潜在障碍。这些障碍包括成本、后勤、跨专业协作、领导层参与以及与院前溶栓相关的信念或怀疑态度。
缺乏战略实施导致循证院前心脏护理的引入不佳,影响了那些原本可能从这种护理水平中受益的弱势群体。鉴于STEMI管理具有时间敏感性,且“初次再灌注”的可及性严重受限,在南非背景下,院前溶栓不仅是一种合理的,也是有吸引力的解决方案。